Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

JCV granule cell neuronopathy and GCN-IRIS under natalizumab treatment.
Autologous hematopoietic stem cell transplantation for multiple sclerosis - if confused or hesitant, remember: 'Treat with standard immune suppressive drugs and if no inflammation, no response'.
Radiologically isolated syndrome - incidental magnetic resonance imaging findings suggestive of multiple sclerosis, a systematic review.
Response to Therapeutic Plasma Exchange as a Rescue Treatment in Clinically Isolated Syndromes and Acute Worsening of Multiple Sclerosis: A Retrospective Analysis of 90 Patients.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Lack of adiponectin leads to increased lymphocyte activation and increased disease severity in a mouse model of multiple sclerosis.
Statin Treatment in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Multiple sclerosis treatment with natalizumab: analysis of a hospital-based cohort.
Imaging Phenotypes in Multiple Sclerosis.
Obstetrical epidural and spinal anesthesia in multiple sclerosis.
Outer retinal changes following acute optic neuritis.
The induction of Treg cells by gut-indigenous Clostridium.
SIRT1 activating compounds reduce oxidative stress and prevent cell death in neuronal cells.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Consensus guidelines for the diagnosis and treatment of multiple sclerosis.
Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts.
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.
Astrocyte loss and astrogliosis in neuroinflammatory disorders.
Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain.
Protective Effect of a cAMP Analogue on Behavioral Deficits and Neuropathological Changes in Cuprizone Model of Demyelination.
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Safety and efficacy of fingolimod in clinical practice: The experience of an academic center in the Middle East.
The behavior-analytic origins of constraint-induced movement therapy: an example of behavioral neurorehabilitation.
Prolactin Is Not Required for the Development of Severe Chronic Experimental Autoimmune Encephalomyelitis.
Evidence for a two-stage disability progression in multiple sclerosis.

Pages